Initial studies found that BMSC from lupus patients compared to matched controls proliferated more slowly, and had a flattened morphology, increased ROS, increased expression of p16INK4a, and increased activation of the p53/p21 pathway [42–46]. Here, TP53 is linked to systemic lupus erythematosus.